American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Emergent Biosolutions, Inc.

EBS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

EBS historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of EBS by members of U.S. Congress

Politician Type Traded
Steve Cohen House / D Sale $1,001 - $15,000 Dec 11, 2024
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov 05, 2021
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct 18, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep 15, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb 23, 2021
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Nov 24, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Jul 30, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Jun 30, 2020
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jun 26, 2020
Gilbert Ray Cisneros, Jr. House / D Purchase $1,001 - $15,000 Jun 19, 2020
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jun 15, 2020
Steve Cohen House / D Sale $1,001 - $15,000 Mar 26, 2020
Steve Cohen House / D Sale $15,001 - $50,000 Aug 29, 2019
EBS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
EBS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EBS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in EBS holdings by institutional investors

Insider Trading

Quarterly net insider trading by EBS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $510,000 Jul 14, 2026 Issue: Budget/Appropriations Health Issues Homeland Security Disaster Planning/Emergencies
  • $730,000 Apr 14, 2026 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $430,000 Jan 16, 2026 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $530,000 Oct 15, 2025 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $440,000 Jul 16, 2025 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $920,000 Apr 15, 2025 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $650,000 Jan 16, 2025 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations Health Issues
  • $500,000 Oct 16, 2024 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $460,000 Jul 15, 2024 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $20,000 Feb 05, 2024 Issue: Health Issues Defense Disaster Planning/Emergencies Budget/Appropriations
  • $50,000 Jan 22, 2024 Issue: Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $50,000 Jan 22, 2024 Issue: Aviation/Airlines/Airports Health Issues
  • $45,000 Jan 21, 2024 Issue: Homeland Security Health Issues Disaster Planning/Emergencies Budget/Appropriations
  • $50,000 Jan 21, 2024 Issue: Disaster Planning/Emergencies
  • $50,000 Jan 19, 2024 Issue: Health Issues
  • $40,000 Jan 19, 2024 Issue: Aviation/Airlines/Airports Aerospace Health Issues Budget/Appropriations
  • $50,000 Jan 19, 2024 Issue: Health Issues
  • $450,000 Oct 16, 2023 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $720,000 Jul 17, 2023 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $640,000 Jan 18, 2023 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $520,000 Oct 17, 2022 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $590,000 Jul 18, 2022 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $1,010,000 Apr 18, 2022 Issue: Health Issues Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $550,000 Jan 18, 2022 Issue: None
  • $530,000 Oct 20, 2021 Issue: None
  • $630,000 Jul 19, 2021 Issue: None
  • $1,470,000 Apr 19, 2021 Issue: None
  • $900,000 Jan 20, 2021 Issue: None
  • $700,000 Oct 19, 2020 Issue: None
  • $990,000 Jul 17, 2020 Issue: None
  • $1,080,000 Apr 17, 2020 Issue: None
  • $730,000 Jan 20, 2020 Issue: None
  • $670,000 Oct 18, 2019 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $740,000 Jul 18, 2019 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations
  • $1,620,000 Apr 22, 2019 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $790,000 Jan 22, 2019 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $600,000 Oct 22, 2018 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $580,000 Jul 20, 2018 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $850,000 Apr 19, 2018 Issue: Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $590,000 Jan 22, 2018 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $580,000 Oct 20, 2017 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies
  • $570,000 Jul 20, 2017 Issue: Budget/Appropriations Disaster Planning/Emergencies Homeland Security
  • $980,000 Apr 20, 2017 Issue: Homeland Security Disaster Planning/Emergencies Budget/Appropriations
  • $420,000 Jan 21, 2017 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,050,000 Oct 17, 2016 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,300,000 Jul 18, 2016 Issue: Medical/Disease Research/Clinical Labs Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,020,000 Apr 18, 2016 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,250,000 Jan 19, 2016 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,230,000 Oct 15, 2015 Issue: Homeland Security Disaster Planning/Emergencies Defense Budget/Appropriations
  • $710,000 Jul 16, 2015 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,250,000 Apr 17, 2015 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $780,000 Jan 20, 2015 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $1,040,000 Oct 17, 2014 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $910,000 Jul 18, 2014 Issue: Homeland Security Budget/Appropriations Disaster Planning/Emergencies Defense
  • $990,000 Apr 21, 2014 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies Defense
  • $680,000 Jan 20, 2014 Issue: Homeland Security Defense Health Issues Budget/Appropriations
  • $640,000 Oct 17, 2013 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $580,000 Jul 17, 2013 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $850,000 Apr 19, 2013 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $630,000 Jan 22, 2013 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $730,000 Oct 22, 2012 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $710,000 Jul 11, 2012 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $1,140,000 Apr 19, 2012 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $690,000 Jan 19, 2012 Issue: Homeland Security Budget/Appropriations Health Issues Disaster Planning/Emergencies
  • $630,000 Oct 19, 2011 Issue: Homeland Security Health Issues Disaster Planning/Emergencies
  • $890,000 Jul 19, 2011 Issue: Homeland Security Health Issues Disaster Planning/Emergencies
  • $1,010,000 Apr 19, 2011 Issue: Homeland Security Health Issues Disaster Planning/Emergencies
  • $590,000 Jan 19, 2011 Issue: Homeland Security
  • $760,000 Oct 18, 2010 Issue: Homeland Security
  • $730,000 Jul 19, 2010 Issue: Homeland Security
  • $830,000 Apr 20, 2010 Issue: Homeland Security
  • $680,000 Jan 20, 2010 Issue: Homeland Security
  • $590,000 Oct 16, 2009 Issue: Homeland Security
  • $610,000 Jul 20, 2009 Issue: Homeland Security
  • $740,000 Apr 20, 2009 Issue: Homeland Security
  • $628,000 Jan 15, 2009 Issue: Homeland Security
  • $575,000 Oct 17, 2008 Issue: Homeland Security
  • $560,000 Jul 14, 2008 Issue: Homeland Security
  • $550,000 Apr 17, 2008 Issue: Homeland Security
  • $1,280,000 Jan 22, 2008 Issue: Homeland Security
  • $1,300,000 Jul 26, 2007 Issue: Homeland Security
  • $1,160,000 Feb 06, 2007 Issue: Homeland Security
  • $700,000 Aug 22, 2006 Issue: Medical/Disease Research/Clinical Labs Government Issues Science/Technology Homeland Security Defense
  • $700,000 Jul 29, 2006 Issue: Science/Technology Defense Government Issues Homeland Security Medical/Disease Research/Clinical Labs
  • $140,000 Aug 15, 2005 Issue: Medical/Disease Research/Clinical Labs
  • $40,000 Aug 10, 2005 Issue: Health Issues Defense Homeland Security Medical/Disease Research/Clinical Labs
  • $20,000 Feb 23, 2005 Issue: Defense Health Issues Medical/Disease Research/Clinical Labs
  • $20,000 Aug 03, 2004 Issue: Health Issues Defense
  • $10,000 Jul 14, 2004 Issue: Health Issues Defense
  • $20,000 Aug 04, 2003 Issue: Health Issues Defense
  • $20,000 Feb 28, 2003 Issue: Health Issues Defense
  • $20,000 Aug 14, 2002 Issue: Defense Health Issues
  • $40,000 Mar 29, 2002 Issue: Defense Health Issues
  • $60,000 Aug 06, 2001 Issue: Defense
  • $80,000 Feb 12, 2001 Issue: Defense
  • $60,000 Aug 09, 2000 Issue: Medical/Disease Research/Clinical Labs Defense Copyright/Patent/Trademark Health Issues Medicare/Medicaid
  • $40,000 Feb 17, 2000 Issue: Defense
Revolving Door

Former government officials who have lobbied for EBS

56 former government officials from 32 congressional offices at 16 lobbying firms have lobbied for EBS, most recently Apr 15, 2026.

  • Dina Titus
    Karen Stone House New Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY). Formerly with Dina Titus · CAPITOL COUNSEL LLC · Apr 15, 2026
  • Hannah Schmidt House Professional Staff, House Small Business Cmte Formerly Professional Staff, House Small Business Cmte · ALPINE GROUP PARTNERS, LLC. · Jan 17, 2026
  • Anna G. Eshoo
    Erin Mendelsohn House LD, Rep. Anna Eshoo; Congressional Liaison - FDA Formerly with Anna G. Eshoo · ALPINE GROUP PARTNERS, LLC. · Jan 17, 2026
  • A. Donald McEachin
    Keenan Austin Reed House Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson Formerly with A. Donald McEachin · ALPINE GROUP PARTNERS, LLC. · Jan 20, 2025
  • Tim Scott
    Shayne Woods Senate New Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus Bilirakis Formerly with Tim Scott · ALPINE GROUP PARTNERS, LLC. · Jan 20, 2025
  • Sam Johnson
    David Heil House Congressman Sam Johnson Formerly with Sam Johnson · THE OB-C GROUP, LLC · Nov 07, 2024
  • Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee Formerly Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legis · TODD STRATEGY GROUP · Nov 21, 2023
  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Nov 21, 2023
See all 56 on the Revolving Door dashboard
Corporate Lobbying

EBS Estimated quarterly lobbying spending

Revenue Breakdown

EBS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
EBS Income Statement
EBS Balance Sheet
EBS Cash Flow
U.S. Patents

New EBS patent grants

  • Patent Title: Stable anthrax vaccine formulations Jul. 15, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to EBS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
EBS News

Recent insights relating to EBS

CNBC Recommendations

Recent picks made for EBS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EBS

EBS Analyst Ratings

EBS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EBS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EBS stock a Buy, Sell, or Hold?

  • What is the price target for $EBS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EBS Top Shareholders
Shareholder
Shares Held
EBS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EBS stock?

  • Who owns the most shares of $EBS stock?

  • What funds own $EBS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EBS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EBS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About EBS

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

  • Address Gaithersburg, MD
  • Market Cap 348.1 million
  • Employees 900
  • Industrial Classification Pharmaceutical Preparations

Emergent Biosolutions, Inc. (EBS) Historical Stock Prices

Emergent Biosolutions, Inc. (EBS) closed at $6.79 on September 25, 2026. Over the past year its adjusted close ranged from $4.45 to $13.90. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month+13.74%
  • 3 months-20.40%
  • Year to date-45.06%
  • 1 year-22.31%
  • 3 years+107.65%
  • 5 years-87.04%
  • Max-69.91%
See every congressional and insider trade on the EBS price chart

Quiver Premium charts EBS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 6.79 6.84 6.67 6.79 6.79 631,361
Sep 24, 2026 6.60 6.87 6.56 6.77 6.77 914,341
Sep 23, 2026 6.73 6.86 6.58 6.67 6.67 1,055,097
Sep 22, 2026 6.61 6.89 6.54 6.76 6.76 1,144,157
Sep 21, 2026 6.80 6.90 6.48 6.55 6.55 1,512,584
Sep 18, 2026 6.98 7.04 6.77 6.80 6.80 1,874,479
Sep 17, 2026 6.84 7.05 6.79 7.02 7.02 1,378,605
Sep 16, 2026 6.40 6.80 6.39 6.75 6.75 1,610,165
Sep 15, 2026 6.36 6.47 6.23 6.36 6.36 1,023,428
Sep 14, 2026 6.21 6.50 6.17 6.38 6.38 685,146
Sep 11, 2026 5.98 6.39 5.88 6.23 6.23 1,299,158
Sep 10, 2026 5.59 5.99 5.50 5.87 5.87 2,391,940
Sep 9, 2026 5.96 6.04 5.61 5.68 5.68 1,174,066
Sep 8, 2026 6.15 6.15 5.96 6.00 6.00 703,242
Sep 4, 2026 6.26 6.30 6.14 6.21 6.21 998,574
Sep 3, 2026 6.56 6.60 5.97 6.23 6.23 1,098,035
Sep 2, 2026 6.23 6.50 6.23 6.46 6.46 1,034,061
Sep 1, 2026 6.16 6.29 6.00 6.22 6.22 972,440
Aug 31, 2026 5.88 6.12 5.80 6.10 6.10 1,126,461
Aug 28, 2026 5.96 6.11 5.88 5.91 5.91 1,244,042
Aug 27, 2026 5.98 6.00 5.75 5.94 5.94 1,304,342
Aug 26, 2026 5.56 6.00 5.55 5.97 5.97 1,165,906
Aug 25, 2026 5.20 5.67 5.20 5.64 5.64 1,362,809
Aug 24, 2026 5.02 5.22 5.00 5.18 5.18 871,184
Aug 21, 2026 4.79 5.11 4.75 5.08 5.08 1,418,590
Aug 20, 2026 4.88 4.93 4.58 4.82 4.82 1,509,459
Aug 19, 2026 4.81 4.92 4.74 4.89 4.89 1,593,454
Aug 18, 2026 4.46 4.67 4.46 4.66 4.66 746,278
Aug 17, 2026 4.50 4.58 4.43 4.50 4.50 695,643
Aug 14, 2026 4.50 4.67 4.45 4.59 4.59 1,095,416
Aug 13, 2026 4.52 4.73 4.45 4.49 4.49 1,461,108
Aug 12, 2026 4.42 4.64 4.38 4.55 4.55 1,698,371
Aug 11, 2026 4.47 4.53 4.37 4.45 4.45 1,755,488
Aug 10, 2026 4.72 4.72 4.36 4.47 4.47 4,332,817
Aug 7, 2026 5.40 5.55 4.81 4.84 4.84 3,140,679
Aug 6, 2026 5.95 5.97 5.06 5.31 5.31 4,259,324
Aug 5, 2026 7.64 7.70 7.52 7.54 7.54 729,015
Aug 4, 2026 7.46 7.63 7.35 7.57 7.57 489,104
Aug 3, 2026 7.38 7.42 7.20 7.41 7.41 441,012
Jul 31, 2026 7.28 7.32 7.05 7.22 7.22 487,190
Jul 30, 2026 7.32 7.45 7.19 7.26 7.26 472,188
Jul 29, 2026 7.25 7.46 7.19 7.35 7.35 572,660
Jul 28, 2026 7.34 7.43 7.21 7.31 7.31 576,059
Jul 27, 2026 7.36 7.50 7.29 7.33 7.33 634,629
Jul 24, 2026 7.51 7.65 7.24 7.26 7.26 554,005
Jul 23, 2026 7.50 7.60 7.46 7.50 7.50 661,151
Jul 22, 2026 7.65 7.73 7.56 7.58 7.58 389,703
Jul 21, 2026 7.62 7.67 7.56 7.65 7.65 440,792
Jul 20, 2026 7.57 7.71 7.49 7.69 7.69 579,485
Jul 17, 2026 7.49 7.67 7.49 7.63 7.63 604,326
Jul 16, 2026 7.85 7.92 7.63 7.69 7.69 846,912
Jul 15, 2026 7.52 7.92 7.42 7.89 7.89 861,704
Jul 14, 2026 7.95 8.01 7.39 7.50 7.50 1,204,676
Jul 13, 2026 7.97 8.15 7.94 8.01 8.01 675,731
Jul 10, 2026 8.20 8.23 7.93 8.05 8.05 1,205,669
Jul 9, 2026 8.14 8.37 8.04 8.18 8.18 644,212
Jul 8, 2026 8.13 8.28 8.04 8.14 8.14 847,809
Jul 7, 2026 8.29 8.43 8.16 8.29 8.29 675,388
Jul 6, 2026 8.24 8.30 8.15 8.18 8.18 610,900
Jul 2, 2026 8.39 8.53 8.12 8.28 8.28 575,960
Jul 1, 2026 8.31 8.63 8.27 8.28 8.28 555,463
Jun 30, 2026 8.39 8.52 8.21 8.38 8.38 730,522
Jun 29, 2026 8.55 8.59 8.31 8.46 8.46 695,051
Jun 26, 2026 7.95 8.53 7.95 8.53 8.53 2,119,446
Jun 25, 2026 8.38 8.45 7.85 7.98 7.98 971,297
Jun 24, 2026 8.03 8.54 8.03 8.43 8.43 891,772
Jun 23, 2026 7.80 8.07 7.80 8.01 8.01 838,716
Jun 22, 2026 8.14 8.26 7.83 7.85 7.85 1,558,072
Jun 18, 2026 8.22 8.32 7.89 8.00 8.00 2,229,025
Jun 17, 2026 7.83 8.29 7.83 8.14 8.14 990,619
Jun 16, 2026 8.29 8.34 7.58 7.75 7.75 1,824,427
Jun 15, 2026 8.46 8.49 8.23 8.29 8.29 688,726
Jun 12, 2026 8.33 8.47 8.27 8.32 8.32 476,687
Jun 11, 2026 8.23 8.49 8.11 8.39 8.39 678,008
Jun 10, 2026 7.90 8.25 7.88 8.24 8.24 780,413
Jun 9, 2026 8.00 8.16 7.56 7.95 7.95 818,357
Jun 8, 2026 8.21 8.33 7.99 8.00 8.00 605,400
Jun 5, 2026 8.38 8.51 7.95 8.07 8.07 701,550
Jun 4, 2026 8.03 8.49 8.03 8.44 8.44 935,778
Jun 3, 2026 8.20 8.31 7.68 7.93 7.93 1,042,148
Jun 2, 2026 8.42 8.47 8.13 8.21 8.21 802,446
Jun 1, 2026 9.00 9.00 8.49 8.49 8.49 852,282
May 29, 2026 9.21 9.37 9.11 9.12 9.12 1,157,302
May 28, 2026 8.90 9.40 8.78 9.18 9.18 880,945
May 27, 2026 9.22 9.34 8.97 9.00 9.00 821,109
May 26, 2026 8.54 9.29 8.52 9.13 9.13 1,085,042
May 22, 2026 8.39 8.60 8.35 8.45 8.45 986,683
May 21, 2026 8.16 8.40 8.08 8.37 8.37 554,605
May 20, 2026 8.09 8.40 8.06 8.15 8.15 614,629
May 19, 2026 8.06 8.28 8.00 8.06 8.06 671,996
May 18, 2026 8.27 8.53 8.07 8.13 8.13 863,642
May 15, 2026 8.10 8.18 7.91 7.94 7.94 508,195
May 14, 2026 8.28 8.54 8.14 8.21 8.21 598,734
May 13, 2026 8.42 8.50 8.30 8.33 8.33 574,935
May 12, 2026 8.83 8.95 8.34 8.50 8.50 606,459
May 11, 2026 9.59 9.66 8.95 8.95 8.95 633,563
May 8, 2026 9.13 9.64 9.10 9.50 9.50 982,476
May 7, 2026 9.07 9.51 9.04 9.13 9.13 654,970
May 6, 2026 9.17 9.37 9.08 9.10 9.10 664,903
May 5, 2026 8.69 9.54 8.67 9.05 9.05 1,336,892
May 4, 2026 8.38 8.63 8.25 8.54 8.54 839,195
May 1, 2026 8.99 9.32 7.53 8.47 8.47 1,407,422
Apr 30, 2026 8.06 8.37 7.99 8.23 8.23 824,832
Apr 29, 2026 8.20 8.20 7.85 7.99 7.99 604,626
Apr 28, 2026 8.10 8.23 8.10 8.23 8.23 572,377
Apr 27, 2026 8.00 8.21 8.00 8.03 8.03 456,155
Apr 24, 2026 8.06 8.09 7.97 8.03 8.03 398,647
Apr 23, 2026 8.24 8.30 7.99 8.09 8.09 325,741
Apr 22, 2026 8.11 8.32 8.09 8.29 8.29 404,081
Apr 21, 2026 8.31 8.39 7.96 8.00 8.00 564,869
Apr 20, 2026 8.68 8.79 8.33 8.35 8.35 546,631
Apr 17, 2026 8.90 9.02 8.70 8.81 8.81 604,170
Apr 16, 2026 8.63 8.80 8.44 8.62 8.62 537,081
Apr 15, 2026 8.64 8.77 8.60 8.66 8.66 457,271
Apr 14, 2026 8.29 8.84 8.29 8.66 8.66 800,599
Apr 13, 2026 7.86 8.26 7.85 8.24 8.24 551,064
Apr 10, 2026 8.40 8.40 7.93 7.96 7.96 595,990
Apr 9, 2026 8.25 8.53 8.25 8.45 8.45 415,670
Apr 8, 2026 8.15 8.39 8.11 8.39 8.39 635,572
Apr 7, 2026 8.00 8.08 7.74 7.85 7.85 1,320,484
Apr 6, 2026 8.21 8.32 8.09 8.10 8.10 557,886
Apr 2, 2026 8.22 8.36 8.06 8.23 8.23 880,373
Apr 1, 2026 8.34 8.54 8.34 8.38 8.38 912,855
Mar 31, 2026 8.26 8.34 8.15 8.30 8.30 760,323
Mar 30, 2026 8.10 8.14 7.94 8.05 8.05 833,655
Mar 27, 2026 8.03 8.15 7.90 7.93 7.93 639,797
Mar 26, 2026 8.21 8.43 8.01 8.08 8.08 927,912
Mar 25, 2026 8.12 8.45 8.12 8.21 8.21 880,098
Mar 24, 2026 7.96 8.10 7.87 8.01 8.01 780,253
Mar 23, 2026 8.21 8.38 7.93 8.05 8.05 844,488
Mar 20, 2026 8.14 8.23 7.97 8.19 8.19 2,027,340
Mar 19, 2026 7.94 8.21 7.85 8.08 8.08 696,913
Mar 18, 2026 8.03 8.11 7.97 8.00 8.00 604,876
Mar 17, 2026 8.42 8.43 8.08 8.08 8.08 728,384
Mar 16, 2026 8.21 8.40 8.17 8.33 8.33 530,221
Mar 13, 2026 8.23 8.44 8.01 8.07 8.07 641,430
Mar 12, 2026 8.03 8.28 8.01 8.13 8.13 728,092
Mar 11, 2026 8.26 8.44 8.16 8.18 8.18 504,874
Mar 10, 2026 8.47 8.59 8.35 8.39 8.39 944,172
Mar 9, 2026 8.20 8.44 7.97 8.35 8.35 1,183,522
Mar 6, 2026 8.12 8.41 8.12 8.29 8.29 918,695
Mar 5, 2026 8.61 8.75 8.34 8.44 8.44 1,393,700
Mar 4, 2026 8.90 9.03 8.66 8.77 8.77 1,721,490
Mar 3, 2026 8.56 9.05 8.45 8.92 8.92 1,651,894
Mar 2, 2026 8.12 9.18 7.81 8.99 8.99 2,354,315
Feb 27, 2026 8.20 9.57 8.00 8.15 8.15 4,650,297
Feb 26, 2026 11.18 11.46 10.96 11.10 11.10 1,465,158
Feb 25, 2026 11.04 11.28 10.86 11.01 11.01 1,071,752
Feb 24, 2026 10.87 11.21 10.73 10.96 10.96 1,052,287
Feb 23, 2026 10.87 11.15 10.65 10.95 10.95 507,919
Feb 20, 2026 10.80 11.23 10.71 10.93 10.93 567,590
Feb 19, 2026 10.60 11.09 10.54 10.99 10.99 494,807
Feb 18, 2026 10.65 10.95 10.65 10.78 10.78 382,100
Feb 17, 2026 10.79 11.08 10.65 10.70 10.70 358,477
Feb 13, 2026 11.00 11.23 10.74 10.83 10.83 626,133
Feb 12, 2026 11.09 11.12 10.67 10.85 10.85 464,725
Feb 11, 2026 11.13 11.26 10.66 11.03 11.03 489,641
Feb 10, 2026 11.04 11.45 10.99 11.04 11.04 563,339
Feb 9, 2026 10.80 11.08 10.45 11.03 11.03 561,684
Feb 6, 2026 10.65 10.96 10.40 10.92 10.92 975,071
Feb 5, 2026 11.19 11.68 10.48 10.54 10.54 905,042
Feb 4, 2026 11.46 11.80 11.29 11.41 11.41 740,966
Feb 3, 2026 11.58 11.96 11.36 11.54 11.54 680,509
Feb 2, 2026 11.33 11.85 11.28 11.71 11.71 485,540
Jan 30, 2026 11.71 12.05 11.29 11.34 11.34 566,876
Jan 29, 2026 11.71 12.13 11.62 11.90 11.90 589,765
Jan 28, 2026 12.23 12.30 11.53 11.71 11.71 459,023
Jan 27, 2026 11.93 12.26 11.87 12.22 12.22 423,793
Jan 26, 2026 11.92 12.10 11.80 11.91 11.91 508,529
Jan 23, 2026 12.09 12.43 11.77 11.95 11.95 541,000
Jan 22, 2026 11.54 12.58 11.54 12.09 12.09 1,264,006
Jan 21, 2026 11.11 11.64 11.11 11.50 11.50 1,274,391
Jan 20, 2026 10.63 11.32 10.60 11.10 11.10 1,416,745
Jan 16, 2026 11.01 11.47 10.90 10.99 10.99 1,726,534
Jan 15, 2026 12.39 12.52 10.91 10.95 10.95 1,868,726
Jan 14, 2026 12.20 12.57 12.01 12.54 12.54 1,370,203
Jan 13, 2026 12.30 12.60 12.13 12.17 12.17 669,527
Jan 12, 2026 12.82 12.83 11.54 12.39 12.39 1,045,908
Jan 9, 2026 13.36 13.53 12.93 12.96 12.96 616,890
Jan 8, 2026 13.80 13.99 13.18 13.36 13.36 1,048,445
Jan 7, 2026 13.37 14.06 13.30 13.90 13.90 1,257,691
Jan 6, 2026 12.72 13.58 12.72 13.15 13.15 1,062,572
Jan 5, 2026 12.45 12.95 12.35 12.85 12.85 934,184
Jan 2, 2026 12.38 12.60 12.15 12.51 12.51 606,904
Dec 31, 2025 12.21 12.47 12.11 12.36 12.36 653,859
Dec 30, 2025 12.13 12.32 12.03 12.16 12.16 545,386
Dec 29, 2025 12.34 12.51 12.02 12.22 12.22 567,024
Dec 26, 2025 12.61 12.63 12.27 12.43 12.43 672,191
Dec 24, 2025 12.59 12.86 12.51 12.63 12.63 322,004
Dec 23, 2025 12.69 12.78 12.20 12.54 12.54 694,238
Dec 22, 2025 12.42 12.95 12.36 12.81 12.81 915,711
Dec 19, 2025 12.36 12.72 12.35 12.42 12.42 1,806,244
Dec 18, 2025 12.30 12.71 12.19 12.30 12.30 730,427
Dec 17, 2025 12.07 12.65 12.06 12.21 12.21 684,452
Dec 16, 2025 12.25 12.63 12.08 12.19 12.19 671,040
Dec 15, 2025 11.38 12.47 11.38 12.33 12.33 1,069,098
Dec 12, 2025 11.77 11.85 11.34 11.41 11.41 568,158
Dec 11, 2025 11.53 11.80 11.46 11.72 11.72 651,324
Dec 10, 2025 11.46 11.62 11.16 11.56 11.56 1,285,023
Dec 9, 2025 11.67 11.99 11.60 11.62 11.62 495,228
Dec 8, 2025 12.01 12.09 11.65 11.87 11.87 1,341,889
Dec 5, 2025 12.15 12.24 11.85 11.90 11.90 696,254
Dec 4, 2025 11.60 12.28 11.52 12.05 12.05 1,124,822
Dec 3, 2025 11.00 11.69 10.97 11.60 11.60 888,666
Dec 2, 2025 10.89 11.17 10.63 10.85 10.85 676,002
Dec 1, 2025 11.06 11.17 10.76 10.79 10.79 731,128
Nov 28, 2025 11.16 11.30 11.11 11.17 11.17 346,920
Nov 26, 2025 10.95 11.18 10.77 11.05 11.05 618,725
Nov 25, 2025 10.85 11.08 10.73 10.95 10.95 859,790
Nov 24, 2025 10.04 10.93 10.04 10.81 10.81 1,143,860
Nov 21, 2025 9.05 10.17 9.02 10.04 10.04 1,129,143
Nov 20, 2025 10.00 10.21 9.07 9.08 9.08 1,155,431
Nov 19, 2025 10.12 10.29 9.76 9.89 9.89 682,892
Nov 18, 2025 10.01 10.21 9.91 10.12 10.12 644,323
Nov 17, 2025 10.04 10.39 9.99 10.10 10.10 806,204
Nov 14, 2025 10.02 10.33 9.93 10.11 10.11 1,137,246
Nov 13, 2025 10.59 11.00 10.21 10.32 10.32 1,087,672
Nov 12, 2025 10.88 11.02 10.72 10.81 10.81 587,480
Nov 11, 2025 10.99 11.00 10.68 10.88 10.88 747,403
Nov 10, 2025 10.35 11.01 10.31 10.99 10.99 1,286,718
Nov 7, 2025 10.00 10.23 9.71 10.16 10.16 1,076,111
Nov 6, 2025 10.31 10.51 10.13 10.27 10.27 949,686
Nov 5, 2025 10.03 10.37 9.91 10.34 10.34 1,330,720
Nov 4, 2025 10.21 10.54 10.04 10.09 10.09 1,198,514
Nov 3, 2025 12.49 12.65 10.16 10.49 10.49 2,861,094
Oct 31, 2025 12.77 13.00 11.62 12.48 12.48 2,364,253
Oct 30, 2025 10.86 13.41 10.84 12.84 12.84 8,917,211
Oct 29, 2025 9.59 9.66 9.21 9.40 9.40 1,131,319
Oct 28, 2025 9.70 9.82 9.42 9.47 9.47 673,131
Oct 27, 2025 9.91 10.01 9.61 9.69 9.69 942,036
Oct 24, 2025 9.85 10.04 9.74 9.74 9.74 640,413
Oct 23, 2025 9.55 9.74 9.43 9.66 9.66 623,348
Oct 22, 2025 9.45 9.54 9.13 9.43 9.43 616,113
Oct 21, 2025 9.83 9.90 9.43 9.45 9.45 628,320
Oct 20, 2025 9.37 9.95 9.35 9.83 9.83 784,862
Oct 17, 2025 9.30 9.62 9.04 9.16 9.16 791,678
Oct 16, 2025 9.66 9.90 9.37 9.40 9.40 961,915
Oct 15, 2025 9.26 9.69 9.24 9.60 9.60 739,142
Oct 14, 2025 9.06 9.31 8.97 9.09 9.09 541,602
Oct 13, 2025 9.15 9.40 9.13 9.30 9.30 595,587
Oct 10, 2025 9.97 10.02 9.06 9.07 9.07 1,173,620
Oct 9, 2025 9.98 10.10 9.77 10.04 10.04 853,628
Oct 8, 2025 9.94 10.08 9.67 9.89 9.89 1,050,473
Oct 7, 2025 9.25 10.05 9.21 9.92 9.92 1,573,268
Oct 6, 2025 9.17 9.39 8.85 9.14 9.14 769,186
Oct 3, 2025 9.23 9.36 9.11 9.15 9.15 588,974
Oct 2, 2025 9.18 9.30 9.03 9.19 9.19 617,509
Oct 1, 2025 8.77 9.34 8.58 9.19 9.19 1,021,413
Sep 30, 2025 8.84 9.10 8.78 8.82 8.82 749,959
Sep 29, 2025 8.95 9.09 8.76 8.94 8.94 890,713
Sep 26, 2025 8.87 9.11 8.61 8.91 8.91 1,366,253
Sep 25, 2025 8.20 8.84 8.10 8.74 8.74 1,394,853

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Emergent Biosolutions, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at EBS, per a recent SEC DEF 14A filing. We estimate that the median employee at Emergent BioSolutions Inc. is paid $130,553.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation